News
Why Kinder Morgan, Ambac Financial, and Sarepta Therapeutics Jumped Today
Stocks didn't move much on Thursday, and major benchmarks were narrowly mixed as earnings season kicked into full gear. Healthcare and utility stocks were generally higher, but the industrials and
Why Sarepta Therapeutics Stock Is Rising Today
Shares of the orphan drug specialist Sarepta Therapeutics (NASDAQ: SRPT) rose by as much as 15.5% in after-hours trading yesterday on heavy volume. This double-digit rally was sparked by a far
Why Sarepta Therapeutics Stock Rose After-Hours Wednesday
Shares of the orphan drug specialist Sarepta Therapeutics (NASDAQ: SRPT) rose by as much as 15.5% in after-hours trading yesterday on heavy volume. This double-digit rally was sparked by a far
Vertex Pharmaceuticals Stock Is Soaring: Here's Why It's Still Not Too Late to Buy
Just last week, I wrote why you'd be smart to buy Vertex Pharmaceuticals (NASDAQ: VRTX) stock. At that time, Vertex was up around 70% for the year. My argument then was that the stock was still
Intuitive Surgical, Inc. in 3 Charts
It's still early, but Intuitive Surgical (NASDAQ: ISRG) stock could be on track to turn in its best performance of this decade. Shares of the robotic surgical systems company are up nearly 50% so far
5 Off-the-Radar Numbers to Take Note of in Johnson & Johnson's Second-Quarter Report
It's officially earnings season, which can only mean one thing: Johnson & Johnson (NYSE: JNJ) is kicking things off for big pharmaceutical companies.On Tuesday morning, July 18, Johnson & Johnson
Why Vertex Pharmaceuticals Incorporated Stock Is Soaring Today
Shares of rare-disease drugmaker Vertex Pharmaceuticals (NASDAQ: VRTX) are on the rise this morning thanks to the extremely positive data readouts for three trials assessing three different triple
Better Buy: Masimo Corporation vs. Zimmer Biomet Holdings Inc.
Over the past several years, Masimo Corporation (NASDAQ: MASI) and Zimmer Biomet Holdings Inc. (NYSE: ZBH) gained leading shares in their respective markets. Outmaneuvering competitors has driven
3 Big Pharma Companies With the Best Projected Return on Investment
Some projections are easier than others. Research firm EvaluatePharma recently published its report of where the pharmaceutical industry could be in 2022. One of the firm's projections was which big
3 Stocks to Supplement Your Social Security Income
Most American retirees depend on Social Security for at least half their retirement income. While it has been a reliable source of income for generations, Social Security's future looks a lot shakier
Does Puma Biotechnology's Approval Make It Worth More?
Puma Biotechnology's (NASDAQ: PBYI) roller-coaster ride to approval is finally over. After fits and starts in clinical trials, the FDA gave the company's breast cancer drug, Nerlynx, a green light
UnitedHealth Group's Sales Surge Above $50 Billion, Despite Exiting Obamacare
UnitedHealth Group's (NYSE: UNH) decision to stop selling Obamacare plans this year hasn't dented its momentum. The nation's biggest health insurer reported sales of $50 billion in the second quarter
How Risky Is Organovo Holdings, Inc.?
You probably won't be shocked to learn that Organovo Holdings, Inc. (NASDAQ: ONVO) has historically been a risky stock. After all, the share price of the 3D bioprinting company dropped nearly 36% in
Here's Why Quidel Corporation Is Rising Today
Shares of Quidel Corporation (NASDAQ: QDEL), a company focused on diagnostic testing equipment, rose 11% as of 11:45 a.m. EDT on Tuesday in response to the announcement that it is acquiring a few
UnitedHealth Sees a Healthier Future
Healthcare is front and center in Washington once more, and lawmakers have made little progress toward making anticipated changes on the insurance front. In the absence of more reform efforts, health
Despite Falling Drug Sales, Johnson & Johnson Remains Optimistic
Johnson & Johnson (NYSE: JNJ) owes much of its recent success to the strength of its pharmaceutical division. Even though the company also has extensive exposure to other parts of the healthcare
5 Big Pharma Stocks With the Best Drug Pipelines
Big pharma companies can't rest on their laurels. Continual research and development is critical to ensure long-term success. Some of that R&D pays off more than others, though.Market research firm
5 Ways Gilead Sciences Could Spend Its Cash Hoard
Gilead Sciences (NASDAQ: GILD) has a growth problem.Long known for its enormous HIV franchise and market share, Gilead branched out into hepatitis C (HCV) in 2012. While that market provided plenty of
Forget GW Pharmaceuticals: These 2 Stocks Are Better Buys
Yes, GW Pharmaceuticals (NASDAQ: GWPH) is the biggest marijuana-focused biotech stock on the market. The company's promising cannabinoid Epidiolex could very well become a blockbuster success story in
3 Healthcare Stocks for Ambitious Investors
While we Fools generally prefer to invest in companies that have battle-tested business models, we do recognize that it can be a smart idea to swing for the fences every now and then.So which stocks
4 Things That Matter When Johnson & Johnson Reports Its Second-Quarter Results
It's that time again, folks: Earnings season is kicking into full swing. And with that comes healthcare conglomerate Johnson & Johnson's (NYSE: JNJ) quarterly report, which often sets the tone for the
Should Mazor Robotics' Investors Fear the Incoming Competition?
Many industry experts believe that the robotic surgery market is on the cusp of a dramatic expansion. For example, a recent report from marketsandmarkets.com predicts that the market will grow from
3 Small Biotech Stocks Being Run by Proven Winners
Great leaders are important in any industry, but perhaps they're even more valuable in biotech, where any number of clinical-stage and regulatory obstacles can derail drug research and send share
These 3 Stocks Have Doubled Investors' Money in 2017
The stock market has done well so far in 2017, with gains of almost 10% for the S&P 500 and even greater rises for some other major market benchmarks. A small number of top-performing stocks have done
Will the Drug Pricing Executive Order Help Big Pharma?
The cost of healthcare has climbed at a rate considerably above that of inflation, and high drug costs are a big factor. During his campaign, President Trump indicated that he would take steps to